LEP and Obesity: On the other hand, obesity is also associated with chronic low-grade inflammation, insulin resistance, altered adipokine profiles—including increased leptin and decreased adiponectin—and changes in drug pharmacokinetics, all of which may negatively affect cancer prognosis [14].